Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
62
datasets available to search
ShareScore release 0.9.0
Dataset results
62 results for “Atys”
HAYKALTAROSHLIK SAN'ATI, TARIXI VA RIVOJLANISH ISTIQBOLLARI.
Open the record for dataset details and reuse information.
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
ClinicalTrials.gov study NCT04801758. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
ClinicalTrials.gov study NCT03585296. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA
ClinicalTrials.gov study NCT04247815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
ClinicalTrials.gov study NCT04524858. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
ClinicalTrials.gov study NCT03315689. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
ClinicalTrials.gov study NCT03468855. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
ClinicalTrials.gov study NCT03354637. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
ClinicalTrials.gov study NCT05216224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04481685. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
ClinicalTrials.gov study NCT03551821. IPD Sharing: NO. Countries: 1. Publications: 0.
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
ClinicalTrials.gov study NCT03594227. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
ClinicalTrials.gov study NCT03495817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
ClinicalTrials.gov study NCT05079451. IPD Sharing: YES. Countries: 1. Publications: 0.
ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
ClinicalTrials.gov study NCT03759340. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Methylation profiles predict ATI outcome in the kick-and-kill therapeutic vaccine BCN02 clinical trial [450K]
GEO Series GSE185389. Homo sapiens. 56 samples. Type: Methylation profiling by array.
Sequence determinants of human gene regulatory elements, ATI experiment
GEO Series GSE180144. synthetic construct. 2 samples. Type: Other.
ATI-1777 a topical JAK1/3 inhibitor may benefit atopic dermatitis without systemic drug exposure, results from preclinical development and Phase 2a randomized-control study ATI-1777-AD-201
GEO Series GSE244201. Sus scrofa. 8 samples. Type: Expression profiling by high throughput sequencing.
Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
ClinicalTrials.gov study NCT02824666. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT06585202. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.